184 related articles for article (PubMed ID: 21237236)
21. Tumor formation in liver of conditional β-catenin-deficient mice exposed to a diethylnitrosamine/phenobarbital tumor promotion regimen.
Rignall B; Braeuning A; Buchmann A; Schwarz M
Carcinogenesis; 2011 Jan; 32(1):52-7. PubMed ID: 21047994
[TBL] [Abstract][Full Text] [Related]
22. Hepatoblastoma: glutamine depletion hinders cell viability in the embryonal subtype but high GLUL expression is associated with better overall survival.
Schmidt A; Armento A; Bussolati O; Chiu M; Ellerkamp V; Scharpf MO; Sander P; Schmid E; Warmann SW; Fuchs J
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3169-3181. PubMed ID: 34235580
[TBL] [Abstract][Full Text] [Related]
23. Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of Ctnnb1.
Braeuning A; Sanna R; Huelsken J; Schwarz M
Drug Metab Dispos; 2009 May; 37(5):1138-45. PubMed ID: 19237511
[TBL] [Abstract][Full Text] [Related]
24. Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma.
Takayasu H; Horie H; Hiyama E; Matsunaga T; Hayashi Y; Watanabe Y; Suita S; Kaneko M; Sasaki F; Hashizume K; Ozaki T; Furuuchi K; Tada M; Ohnuma N; Nakagawara A
Clin Cancer Res; 2001 Apr; 7(4):901-8. PubMed ID: 11309340
[TBL] [Abstract][Full Text] [Related]
25. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
26. A common human skin tumour is caused by activating mutations in beta-catenin.
Chan EF; Gat U; McNiff JM; Fuchs E
Nat Genet; 1999 Apr; 21(4):410-3. PubMed ID: 10192393
[TBL] [Abstract][Full Text] [Related]
27. CTNNB1 (beta-catenin) mutation is rare in brain tumours but involved as a sporadic event in a brain metastasis.
Lee CI; Hsu MY; Chou CH; Wang C; Lo YS; Loh JK; Howng SL; Hong YR
Acta Neurochir (Wien); 2009 Sep; 151(9):1107-11. PubMed ID: 19582367
[TBL] [Abstract][Full Text] [Related]
28. Nuclear accumulation of beta-catenin protein in Wilms' tumours.
Koesters R; Niggli F; von Knebel Doeberitz M; Stallmach T
J Pathol; 2003 Jan; 199(1):68-76. PubMed ID: 12474228
[TBL] [Abstract][Full Text] [Related]
29. Beta-catenin mutations and protein accumulation in all hepatoblastomas examined from B6C3F1 mice treated with anthraquinone or oxazepam.
Anna CH; Sills RC; Foley JF; Stockton PS; Ton TV; Devereux TR
Cancer Res; 2000 Jun; 60(11):2864-8. PubMed ID: 10850429
[TBL] [Abstract][Full Text] [Related]
30. Genetic and epigenetic alterations of the APC gene in malignant melanoma.
Worm J; Christensen C; Grønbaek K; Tulchinsky E; Guldberg P
Oncogene; 2004 Jul; 23(30):5215-26. PubMed ID: 15133491
[TBL] [Abstract][Full Text] [Related]
31. Genotype-phenotype relationships in hepatocellular tumors from mice and man.
Stahl S; Ittrich C; Marx-Stoelting P; Köhle C; Altug-Teber O; Riess O; Bonin M; Jobst J; Kaiser S; Buchmann A; Schwarz M
Hepatology; 2005 Aug; 42(2):353-61. PubMed ID: 15965925
[TBL] [Abstract][Full Text] [Related]
32. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
[TBL] [Abstract][Full Text] [Related]
33. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes.
Prange W; Breuhahn K; Fischer F; Zilkens C; Pietsch T; Petmecky K; Eilers R; Dienes HP; Schirmacher P
J Pathol; 2003 Oct; 201(2):250-9. PubMed ID: 14517842
[TBL] [Abstract][Full Text] [Related]
34. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
[TBL] [Abstract][Full Text] [Related]
35. Correlation between beta-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma.
Austinat M; Dunsch R; Wittekind C; Tannapfel A; Gebhardt R; Gaunitz F
Mol Cancer; 2008 Feb; 7():21. PubMed ID: 18282277
[TBL] [Abstract][Full Text] [Related]
36. Selective poisoning of Ctnnb1-mutated hepatoma cells in mouse liver tumors by a single application of acetaminophen.
Singh Y; Braeuning A; Schmid A; Pichler BJ; Schwarz M
Arch Toxicol; 2013 Aug; 87(8):1595-607. PubMed ID: 23479080
[TBL] [Abstract][Full Text] [Related]
37. Zonation of heme synthesis enzymes in mouse liver and their regulation by β-catenin and Ha-ras.
Braeuning A; Schwarz M
Biol Chem; 2010 Nov; 391(11):1305-13. PubMed ID: 20707599
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.
Pendás-Franco N; Aguilera O; Pereira F; González-Sancho JM; Muñoz A
Anticancer Res; 2008; 28(5A):2613-23. PubMed ID: 19035286
[TBL] [Abstract][Full Text] [Related]
39. Focal β-catenin mutation identified on formalin-fixed and paraffin-embedded inflammatory hepatocellular adenomas.
Saldarriaga J; Bisig B; Couchy G; Castain C; Zucman-Rossi J; Balabaud C; Sempoux C; Bioulac-Sage P
Histopathology; 2017 Dec; 71(6):989-993. PubMed ID: 28618047
[TBL] [Abstract][Full Text] [Related]
40. Serum components and activated Ha-ras antagonize expression of perivenous marker genes stimulated by beta-catenin signaling in mouse hepatocytes.
Braeuning A; Menzel M; Kleinschnitz EM; Harada N; Tamai Y; Köhle C; Buchmann A; Schwarz M
FEBS J; 2007 Sep; 274(18):4766-77. PubMed ID: 17697114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
